Replies to post #45751 on Savvy Trades and Investments

[nelson1234]

CNAT was initiated today by Oppenheimer at Outperform with a $16 price target, hence the positive move.

I own some CNAT. But be careful, or be ready if you are buying at some point....they expect news to be out regarding their FDA stage whatever during the second quarter of this year....for better or worse.